Bevacizumab + Erlotinib

Regimen

• Bevacizumab (Avastin) 10 mg/m2 iv over 30-90 min q2w
• Erlotinib (Tarceva) 150 mg po qd

References

Hainsworth JD et al. Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: The Minnie Pearl Cancer Research Network. J Clin Oncol 2007; 25:1747